跳至主要内容
临床试验/NL-OMON48337
NL-OMON48337已完成不适用

Evaluating Hemopatch in reducing seroma related complications following axillary lymph node dissection: a pilot study - HEIDI

Zuyderland Medisch Centrum0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Male and female patients of 18 years or older.
  • - Patients with melanoma and indication for axillary lymph node dissection.
  • - Patients with breast cancer and indication for breast conserving therapy and
  • axillary lymph node dissection
  • - Patients with an indication for secondary axillary lymph node
  • dissection.

排除标准

  • - Patients with breast cancer who have an indication for modified radical
  • mastectomy.
  • - Unable to comprehend implications and extent of study and sign for informed
  • - Pregnant women
  • - Patients included in another breast related clinical trial

研究者

发起方
Zuyderland Medisch Centrum

相似试验